GlassScriptPhysician profile
Nicole M Fuller
NPI 1083742993
$4,355.93
in general payments reported to CMS, 2019-2025
25 companies · $915 in 2025
The $915 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $567 · 2022: $895 · 2023: $926 · 2024: $1,053 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,893.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $891.37 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $595.96 | 2021-2024 | Lifevest |
| Merck Sharp & Dohme LLC | $407.95 | 2021-2025 | Verquvo |
| Abbott Laboratories | $385.65 | 2021-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Merlin@Home |
| Janssen Pharmaceuticals, INC | $368.85 | 2021-2023 | Xarelto |
| Amgen INC. | $367.98 | 2022-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $248.34 | 2024 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.85 | 2022-2025 | Jardiance |
| Pfizer INC. | $89.49 | 2022-2024 | |
| Itamar Medical INC | $88.10 | 2022-2023 | Watchpatone |
| Scpharmaceuticals INC. | $86.21 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $84.58 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $83.78 | 2023-2025 | |
| Lexicon Pharmaceuticals, INC. | $73.05 | 2023-2024 | Inpefa |
| Novo Nordisk INC | $60.45 | 2024-2025 | Wegovy |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $58.27 | 2024-2025 | Impella |
| Irhythm Technologies, INC. | $52.49 | 2023 | Zio Xt Patch |
| Inspire Medical Systems, INC. | $50.82 | 2025 | Inspire |
| Kiniksa Pharmaceuticals, LTD. | $50.56 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $42.96 | 2021-2022 | |
| Alk-Abello, INC | $23.91 | 2022 | |
| Stryker Corporation | $22.91 | 2025 | Clottriever Bold Catheter |
| Philips North America LLC | $22.70 | 2025 | Lm Undivided |
| Medtronic, INC. | $19.14 | 2021 | |
| Alnylam Pharmaceuticals INC. | $16.56 | 2025 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.